Qing Zhou

This inventor holds 8 USPTO granted patents and 10 published patent applications and 4 EPO patents. Top assignees: Corning Incorporated, Genor Biopharma Co., Ltd., Shanghai Escugen Biotechnology Co., Ltd.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qing Zhou. Retrieved from https://idiyas.com/inventor/qing-zhou-lxn3glfc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 10)

% Patents Active = 75.0

EPO Patents = 4 (Patent Applications = 16)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

Genor Biopharma Co., Ltd.

patents

1 out of 1

Shanghai Escugen Biotechnology Co., Ltd.

patent

4. 1 out of 1

Shanghai Escugen Biotechnology Co., Ltd.

patent

Years Active: 2018-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760093 - CLDN18.2 ANTIBODY AND USE THEREOF (2026-10-13),

2. 12685951 - Porous structure such as for filters, and making the same (2026-07-21),

3. 12521697 - Cement plug composition for application to a ceramic honeycomb body and method of forming plugged ceramic honeycomb body with the same (2026-01-13),

4. 12435135 - Human CD47-targeting single-domain antibody and use thereof (2025-10-07),

5. 11878940 - Bioactive glass compositions (2024-01-23),

6. 10253108 - Mutated antibody of fully humanized HER2 antibody, and encoding gene and use thereof (2019-04-09),

7. 10017555 - Long-acting blood sugar decreasing fusion protein (2018-07-10),

8. 9896510 - Anti-human RANKL antibody, humanized antibody of the same, and pharmaceutical composition and use thereof (2018-02-20),

Title: Qing Zhou: Innovator in Biopharmaceuticals and Materials Science

Introduction

Qing Zhou is a prominent inventor based in Shanghai, China, known for her contributions to the fields of biopharmaceuticals and materials science. With a total of five patents to her name, she has made significant strides in developing innovative solutions that address critical health and material challenges.

Latest Patents

Among her latest patents is the "Human CD47-targeting single-domain antibody and use thereof." This application relates to an anti-CD47 single-domain antibody, which includes a method for preparing the antibody. The single-domain antibody comprises specific CDRs selected from designated sequences. Another notable patent is for "Bioactive glass compositions," which details a silicate-based glass composition with precise weight percentages of various oxides, aimed at enhancing material properties for biomedical applications.

Career Highlights

Qing Zhou has worked with notable companies such as Genor Biopharma Co., Ltd. and Corning Incorporated. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in biopharmaceuticals and materials science.

Collaborations

Qing has collaborated with several professionals in her field, including Weihong Nian and Joe Zhou. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Qing Zhou's work exemplifies the spirit of innovation in the realms of biopharmaceuticals and materials science. Her patents and collaborations reflect her commitment to advancing technology for the betterment of society.

Profile summary based on public USPTO records.